United Therapeutics Corporation shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in United Therapeutics Corporation by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $3.9M | 11k | 358.35 |
| 2024-06-30 | $17M | 54k | 318.55 |
| 2024-03-31 | $1.2M | 5.4k | 229.72 |
| 2022-12-31 | $793k | 2.9k | 278.09 |
| 2022-09-30 | $12M | 57k | 209.38 |
| 2022-06-30 | $15M | 61k | 235.64 |
| 2022-03-31 | $9.5M | 53k | 179.41 |
| 2021-12-31 | $8.5M | 39k | 216.08 |
| 2021-09-30 | $2.8M | 15k | 184.60 |
| 2020-12-31 | $646k | 4.3k | 151.71 |
| 2019-09-30 | $3.6M | 45k | 79.74 |
| 2019-06-30 | $5.4M | 69k | 78.06 |
| 2019-03-31 | $2.2M | 19k | 117.38 |
| 2018-12-31 | $4.9M | 45k | 108.91 |
| 2018-09-30 | $7.1M | 55k | 127.88 |
| 2018-06-30 | $8.1M | 71k | 113.15 |
| 2018-03-31 | $7.9M | 70k | 112.36 |
| 2017-12-31 | $12M | 81k | 147.95 |
| 2017-09-30 | $11M | 93k | 117.19 |
| 2017-06-30 | $9.1M | 71k | 129.73 |
| 2016-06-30 | $4.5M | 42k | 105.92 |
| 2016-03-31 | $4.1M | 37k | 111.44 |
| 2015-12-31 | $5.9M | 38k | 156.61 |
| 2015-09-30 | $1.4M | 11k | 131.23 |
| 2014-12-31 | $2.2M | 15k | 150.00 |
| 2014-09-30 | $1.3M | 9.0k | 143.78 |
| 2014-06-30 | $311k | 3.3k | 94.24 |
| 2014-03-31 | $3.7M | 35k | 103.79 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation